At 17.4% CAGR, the Asia Pacific Disposable Endoscope Market is projected to be worth US$ 592.02 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific disposable endoscope market was valued at US$ 225.68 million in 2022 and is expected to reach US$ 592.02 million by 2028, registering a CAGR of 17.4% from 2022 to 2028. Rising incidence of hospital-acquired infections (HAI) due to contaminated endoscopes and increased focus on patient safety and workflow efficiency are the critical factors attributed to the Asia Pacific disposable endoscope market expansion.             

Due to the difficulty in cleaning reusable devices for reuse and persistent contamination levels, the FDA recommends avoiding the use of duodenoscopes with fixed endcaps and replace them with disposable components, including disposable endcaps, or fully disposable duodenoscopes. The FDA urges manufacturers of disposable duodenoscope models to assist healthcare facilities with their transition plans. To reduce or eliminate infection risks for patients, FDA works with manufacturers to increase the supply of disposable caps of duodenoscopes and develop innovative designs of other devices. Currently, the FDA recommends a gradual transition to disposable duodenoscopes because it is not feasible to remove conventional, fixed endcap duodenoscopes completely. Furthermore, the FDA has ordered disposable endcaps from duodenoscope manufacturers to conduct post-market surveillance studies to gather information and verify that the new designs reduce contamination. After the completion of post-market surveillance studies by the FDA, duodenoscopes with disposable end caps are expected to be labeled with contamination rate information. The information would allow patients and healthcare professionals to make informed decisions about the potential risks associated with duodenoscope. Thus, favorable government regulation for disposable endoscopes will provide opportunities for the disposable endoscope market during the forecast period. This is expected to drive the Asia Pacific disposable endoscope market during the forecast period.

On the contrary, accumulation of medical waste due to disposable endoscopes hurdles the growth of Asia Pacific disposable endoscope market. 

Based on application, the Asia Pacific disposable endoscope market is categorized into GI endoscopy, bronchoscopy, urologic endoscopy, arthroscopy, proctoscopy, and others. The GI endoscopy segment held 32.4% share of Asia Pacific disposable endoscope market in 2022, amassing US$ 73.04 million. It is projected to garner US$ 188.64 million by 2028 to expand at 17.1% CAGR during 2022–2028.

Based on end user, the Asia Pacific disposable endoscope market is categorized into hospitals, diagnostic centers, and clinics. The hospitals segment held 52.4% share of Asia Pacific disposable endoscope market in 2022, amassing US$ 118.30 million. It is projected to garner US$ 317.05 million by 2028 to expand at 17.9% CAGR during 2022–2028.

Based on country, the Asia Pacific disposable endoscope market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 29.6% share of Asia Pacific disposable endoscope market in 2022. It was assessed at US$ 66.87 million in 2022 and is likely to hit US$ 180.57 million by 2028, exhibiting a CAGR of 18.0% during the forecast period.            

Key players dominating the Asia Pacific disposable endoscope market are Boston Scientific Corp; Ambu AS; Hill-Rom Services Inc.; Karl Storz SE & Co KG; Flexicare (Group) Ltd; OBP Medical Corp; Parburch Medical Developments Ltd; and Coloplast Corp among others.

• In Aug 2021, Boston Scientific Receives FDA Clearance for EXALT Model B Single-Use Bronchoscope.
• In Feb 2022, Ambu Announced FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com